Charles Russell Speechlys advises the Business Growth Fund (BGF), on the investment by the BGF in Renal Services
Charles Russell Speechlys has advised the Business Growth Fund on its investment in Renal Services, an independent provider of dialysis services to NHS patients.
Headquartered in London, Renal Services was founded in 2007, employs 62 staff and is the fourth largest provider of dialysis in the UK. The company currently runs six dialysis centres across the UK, operating 63 dialysis stations and treating approximately 700 permanent and transient patients on behalf of the NHS. Approximately 95% of treatments are delivered to permanent local patients.
The centres, which were designed and built by Renal Services, are located in Grantham, Havant, Launceston, Milford on Sea, Salisbury and Skegness. The company manages all aspects of dialysis care at its centres including clinical, quality control, data collection, diagnostics and maintenance services. It puts patient experience, choice and outcomes at the centre of its service with an on-going track record in exceeding local and national standards as set out by the Department of Health and the Renal Association.
Rory Pope of the BGF commented “As always, it was a pleasure to work the Charles Russell Speechlys team. Their service and advice was of the usual highest standards and critical to us completing this investment”.
The Charles Russell Speechlys core team comprised Genevieve Morrall from the Private Equity team, with support from members of our Tax, Intellectual Property, Employment and Real Estate teams.
News & Insights
Financing arrangements: the impact of COVID-19 for borrowers
Considering the short and longer term impacts of the COVID-19 pandemic on financing arrangements.
Charles Russell Speechlys advises AIQ Ltd on Main Market readmission and reverse takeover of AI codes
Charles Russell Speechlys has assisted AIQ Ltd on the completion of the acquisition of AI Codes and on Main Market readmission.